Research and analysis

COVID-19: NHS workforce repeat asymptomatic testing evaluation

Understanding the impact of repeat routine lateral flow device (LFD) testing of asymptomatic NHS staff in the secondary care patient-facing NHS workforce during the COVID-19 pandemic.

• From: UK Health Security Agency
• Published: 27 April 2023

Applies to England

Documents

NHS workforce repeat asymptomatic testing: a quantitative evaluation report

Ref: UKHSA publication gateway number GOV-13292

PDF, 991 KB, 70 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Over the first 27 weeks of the testing intervention, there were approximately 40,000 positive results from 10.4 million reported tests from 908,000 people taking part in self-testing using LFDs in the NHS organisation in scope of the evaluation. That is a positivity rate of 0.4% by test, and 4% by individual healthcare worker who took part over the whole evaluation period.

The primary objective of this evaluation was to enable NHS England and NHS Test and Trace (Department of Health and Social Care) to understand the impact of repeat routine lateral flow testing of asymptomatic NHS staff on the detection of coronavirus (COVID-19) infection in the secondary care patient-facing NHS workforce.

Published 27 April 2023